Melanie K.Chan

Associate

纽约 + 1.212.326.3654

联系：

Share

Melanie Chan focuses her practice on complex commercial litigation in state and federal courts. She has also represented clients in bankruptcy, employment matters, and antitrust litigation.

Melanie has significant experience in all phases of discovery, including managing large-volume electronic discovery, taking depositions, and preparing corporate representatives, experts, and fact witnesses for depositions and trial. In addition, Melanie has drafted briefing for numerous cases pending in federal court, successfully representing clients through dispositive motion practice and on appeal.

Melanie also has represented clients in connection with real estate ventures, capital markets transactions, and private financing. She has experience across diverse industry sectors, including the eco-friendly recycling, packaging, and hygiene solution; steel; and nanotechnology industries.

Melanie maintains an active pro bono practice, representing clients in child custody proceedings and immigration matters.

经验

  • Celgene wins complete defense verdict in case filed by health insurer, Humana Inc., relating to off-label use of cancer medicationsOn March 2, 2023, Jones Day prevailed in a five-week jury trial on behalf of Celgene Corporation in a lawsuit brought by health insurance company Humana, Inc.
  • U.S. Steel closes €300 million sustainability linked revolving credit facilityJones Day advised U.S. Steel Košice, s.r.o., a wholly owned subsidiary of United States Steel Corporation and one of the largest integrated steel producers in Central Europe, on its entry into a €300 million sustainability linked revolving credit facility with a syndicate of lenders led by ING Bank N.V.
  • Nanobiotix completes $113.3 million IPO on NasdaqJones Day represented Nanobiotix S.A., a French clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, in connection with its $113.3 million initial public offering in the United States and listing on Nasdaq.
  • Cascades completes US$300 million Rule 144A and Reg S offering of Senior Notes and US$200 million tender offer of Senior NotesJones Day advised Cascades Inc., a Canadian-based company and leader in eco-friendly recycling, packaging, and hygiene solutions, in connection with the issuance of US$300 million in aggregate principal amount of 5.375% Senior Notes due 2028 in a Rule 144A and Regulation S offering, as well as a tender offer for any and all of its outstanding principal amount of US$200 million 5.75% Senior Notes due 2023.
  • Global systemically important bank (GSIB) conducts risk assessment to determine impact of LIBOR transition on enterprise-wide portfoliosJones Day is advising a GSIB with respect to enterprise-wide portfolios impacted by the LIBOR transition, including conducting portfolio-wide risk impact assessments, analyzing various consumer products, and developing litigation contingency plans.
  • Chinese financial leasing company provides $15 million loan to KateevaJones Day represented a Chinese financial leasing company in connection with its $15 million loan provided to Kateeva Inc., a developer of the world's first inkjet printer to manufacture high volumes of flexible OLEDs (organic electroluminescent diodes).
  • U.S. Steel Kosice refinances €460 million senior multicurrency revolving credit facility agreementJones Day advised U.S. Steel Kosice, s.r.o., a Slovak subsidiary of U.S. Steel Corporation, on the refinancing of a €460 million guaranteed senior multicurrency revolving credit facility agreement.
  • China Orient Asset Management provides financing for luxury condominium building in lower ManhattanJones Day advised China Orient Asset Management (International) Holdings Limited (“COAMI”) in connection with a junior mezzanine loan secured by a majority membership interest in a real estate joint venture (the “Venture”).
    •

    发送前请注意

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice